Search research articles
Contact Us
Filters
Showing results (151-160 of 170) with videos related to
Page
of 17
Sort By:
Ugeskrift for Laeger
|
May 14, 1990
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]
J Dyerberg, S Stender, G E Andersen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
February 1, 1994
Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100
P S Hansen, H Meinertz, H K Jensen, et al.
Zeitschrift Fur Gastroenterologie
|
June 1, 1996
A flow cytometric competition technique for measuring interaction of LDL with cellular LDL-receptors applied to patients with mutant (Arg3500-->Gln) apolipoprotein B
F Heath, T G Jensen, P S Hansen, et al.
American Journal of Hypertension
|
May 1, 1992
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension
M A Gall, P Rossing, P Skøtt, et al.
Atherosclerosis. Supplements
|
November 9, 2004
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994
T R Pedersen, J Kjekshus, K Berg, et al.
Clinical Genetics
|
July 1, 1995
Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease
H K Jensen, P S Hansen, L G Jensen, et al.
Lancet (London, England)
|
June 17, 2008
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D A Wood, K Kotseva, S Connolly, et al.
Ugeskrift for Laeger
|
March 1, 1993
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study]
M A Gall, P Rossing, P Skøtt, et al.
Genetika
|
November 10, 2007
[Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect]
F M Zakharova, Iu A Tatishcheva, V I Golubkov, et al.
Clinical Genetics
|
February 11, 2000
Normolipidemia and hypercholesterolemia in persons heterozygous for the same 1592 + 5G --> A splice site mutation in the low-density lipoprotein receptor gene
H K Jensen, L G Jensen, H U Holst, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 170) with videos related to
Sort By:
Page
of 17
Ugeskrift for Laeger
|
May 14, 1990
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]
J Dyerberg, S Stender, G E Andersen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
February 1, 1994
Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100
P S Hansen, H Meinertz, H K Jensen, et al.
Zeitschrift Fur Gastroenterologie
|
June 1, 1996
A flow cytometric competition technique for measuring interaction of LDL with cellular LDL-receptors applied to patients with mutant (Arg3500-->Gln) apolipoprotein B
F Heath, T G Jensen, P S Hansen, et al.
American Journal of Hypertension
|
May 1, 1992
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension
M A Gall, P Rossing, P Skøtt, et al.
Atherosclerosis. Supplements
|
November 9, 2004
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994
T R Pedersen, J Kjekshus, K Berg, et al.
Clinical Genetics
|
July 1, 1995
Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease
H K Jensen, P S Hansen, L G Jensen, et al.
Lancet (London, England)
|
June 17, 2008
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D A Wood, K Kotseva, S Connolly, et al.
Ugeskrift for Laeger
|
March 1, 1993
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study]
M A Gall, P Rossing, P Skøtt, et al.
Genetika
|
November 10, 2007
[Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect]
F M Zakharova, Iu A Tatishcheva, V I Golubkov, et al.
Clinical Genetics
|
February 11, 2000
Normolipidemia and hypercholesterolemia in persons heterozygous for the same 1592 + 5G --> A splice site mutation in the low-density lipoprotein receptor gene
H K Jensen, L G Jensen, H U Holst, et al.
Page
of 17